Dear Sirs, A number of studies have shown that the γ-carboxyglutamate-rich (GLA) domains of vitamin K-dependent clotting proteins require Ca 2+ to fold properly and bind to membranes (1, 2). Although plasma contains about 1.25 mM free Ca 2+ and 0.5 mM Mg 2+ (3), in vitro assays of clotting factor function often employ supraphysiologic Ca 2+ concentrations (2.5-5 mM Ca 2+), and no Mg 2+. Sekiya et al. showed that Mg 2+ enhances factor IX (fIX) structure and function in combination with physiologic Ca 2+ concentrations (4, 5). Subsequent reports showed that, in the presence of plasma concentrations of Ca 2+ , Mg 2+ enhances the activity of factor VIIa (fVIIa) bound to tissue factor (TF) (6-10). The concept is that GLA domains typically bind seven or eight Ca 2+ when it is the only divalent metal ion present (at supraphysiologic Ca 2+ concentrations), but at plasma concentrations of Ca 2+ and Mg 2+ , two or three of these "calcium" binding sites are actually occupied by Mg 2+ , with functional consequences (11). Mg 2+ does not support clotting reactions in the absence of Ca 2+ (12), also consistent with the notion that only a subset of the metal ion binding sites in GLA domains can be productively occupied by Mg 2+ .